Antegrade/retrograde cardioplegia for valve replacement: a prospective study

Area of Science:

• Cardiovascular Surgery
• Cardiac Anesthesia
• Cardioplegia Delivery

Background:

• Study involved 75 patients undergoing valve replacement surgery between 1994-1996.
• Patients were randomized to receive cold blood cardioplegia via antegrade (Group 1) or antegrade/retrograde (Group 2) administration.
• Groups were comparable in terms of age, sex, valve disease, and ventricular dysfunction.

Purpose of the Study:

• To compare the efficacy of antegrade versus antegrade/retrograde administration of cold blood cardioplegia.
• To evaluate potential differences in surgical outcomes and myocardial protection between the two cardioplegia delivery methods.

Main Methods:

• Randomized trial comparing antegrade (n=36) vs. antegrade/retrograde (n=39) cardioplegia.
• Aortic and mitral valve replacements were performed, with one patient undergoing double valve replacement.
• Data collected included cardiopulmonary bypass time, aortic cross-clamp time, cardioplegia volume and infusion duration, and perioperative outcomes.

Main Results:

• Group 2 experienced significantly shorter aortic cross-clamp times (12 minutes shorter, p < 0.05).
• Infusion duration was significantly longer in Group 2 (72% vs. 44% of cross-clamp time, p < 0.01).
• No significant differences were observed in mortality, perioperative myocardial infarction, stroke rates, or peak enzyme release (CK-MB, troponin T).

Conclusions:

• Antegrade/retrograde cardioplegia administration did not demonstrate a significant advantage over the antegrade route in routine valve replacement.
• The primary observed difference was a slightly shorter aortic cross-clamping time with the combined antegrade/retrograde approach.
• Routine valve replacement surgery outcomes were similar between the two cardioplegia delivery methods.